Skip to main content
OpenTrials

Clinical trial condition

Advancing Multiple Sclerosis

Explore clinical trials studying Advancing Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Advancing Multiple Sclerosis trial results

Completed

Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients

NCT03623243

Conditions
Advancing Multiple Sclerosis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +6 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Cullman, Alabama, United States
  • Alabama Neurology Associates Homewood, Alabama, United States
  • Novartis Investigative Site Tucson, Arizona, United States
View all 55 locations
View Trial Details

Related conditions